Literature DB >> 23591956

Rehabilitating rimonabant.

Friedrich C Luft1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23591956     DOI： 10.1007/s00109-013-1039-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  14 in total

1.  Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.

Authors:  Partha Mukhopadhyay; Sándor Bátkai; Mohanraj Rajesh; Nora Czifra; Judith Harvey-White; György Haskó; Zsuzsanna Zsengeller; Norma P Gerard; Lucas Liaudet; George Kunos; Pál Pacher
Journal:  J Am Coll Cardiol       Date:  2007-07-23       Impact factor: 24.094

Review 2.  Evidence for novel cannabinoid receptors.

Authors:  Malcolm Begg; Pál Pacher; Sándor Bátkai; Douglas Osei-Hyiaman; László Offertáler; Fong Ming Mo; Jie Liu; George Kunos
Journal:  Pharmacol Ther       Date:  2005-01-11       Impact factor: 12.310

3.  Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

Authors:  M A Huestis; D A Gorelick; S J Heishman; K L Preston; R A Nelson; E T Moolchan; R A Frank
Journal:  Arch Gen Psychiatry       Date:  2001-04

Review 4.  At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction.

Authors:  Fabrizio Montecucco; Vincenzo Di Marzo
Journal:  Trends Pharmacol Sci       Date:  2012-04-13       Impact factor: 14.819

Review 5.  Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Authors:  P Pacher; R Mechoulam
Journal:  Prog Lipid Res       Date:  2011-02-02       Impact factor: 16.195

6.  Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; Vivek Patel; Keita Saito; Shingo Matsumoto; Yoshihiro Kashiwaya; Béla Horváth; Bani Mukhopadhyay; Lauren Becker; György Haskó; Lucas Liaudet; David A Wink; Aristidis Veves; Raphael Mechoulam; Pál Pacher
Journal:  J Am Coll Cardiol       Date:  2010-12-14       Impact factor: 24.094

Review 7.  Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions.

Authors:  T M Fong; S B Heymsfield
Journal:  Int J Obes (Lond)       Date:  2009-07-14       Impact factor: 5.095

Review 8.  Cannabinoid signalling.

Authors:  Dirk G Demuth; Areles Molleman
Journal:  Life Sci       Date:  2005-08-18       Impact factor: 5.037

9.  Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome.

Authors:  Svetlana Slavic; Dilyara Lauer; Manuela Sommerfeld; Ulrich Rudolf Kemnitz; Aleksandra Grzesiak; Manuela Trappiel; Christa Thöne-Reineke; Johannes Baulmann; Ludovit Paulis; Kai Kappert; Ulrich Kintscher; Thomas Unger; Elena Kaschina
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

10.  The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction.

Authors:  Shiang Y Lim; Sean M Davidson; Derek M Yellon; Christopher C T Smith
Journal:  Basic Res Cardiol       Date:  2009-05-22       Impact factor: 17.165
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.